Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer

by Maric, Gordana, Rose, April AN, Annis, Matthew G, Siegel, Peter M
Published 2013

Arsenic Trioxide Overcomes Rapamycin-Induced Feedback Activation of AKT and ERK Signaling to Enhance the Anti-Tumor Effects in Breast Cancer

by Guilbert, Cynthia, Annis, Matthew G., Dong, Zhifeng, Siegel, Peter M., Miller, Wilson H., Mann, Koren K.
Published 2013

Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray*

by Li, Huiyan, Bergeron, Sébastien, Annis, Matthew G., Siegel, Peter M., Juncker, David
Published 2015

Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis

by Tabariès, Sébastien, Annis, Matthew G., Hsu, Brian E., Tam, Christine E., Savage, Paul, Park, Morag, Siegel, Peter M.
Published 2015

Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases

by Tabariès, Sébastien, Ouellet, Véronique, Hsu, Brian E, Annis, Matthew G, Rose, April AN, Meunier, Liliane, Carmona, Euridice, Tam, Christine E, Mes-Masson, Anne-Marie, Siegel, Peter M
Published 2015

LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer

by Dupuy, Fanny, Griss, Takla, Blagih, Julianna, Bridon, Gäelle, Avizonis, Daina, Ling, Chen, Dong, Zhifeng, Siwak, Doris R, Annis, Matthew G, Mills, Gordon B, Muller, William J, Siegel, Peter M, Jones, Russell G
Published 2013